title: Acetaminophen (Tylenol): Johnson & Johnson and consumer safety.
abstract: Considers, against backdrop of Johnson & Johnson's handling of the Tylenol poisonings of the 1980s, Johnson & Johnson's response to product safety concerns raised about acetaminophen by studies suggesting links to hepatotoxicity and end-stage renal disease.
authors.affiliation: St. John's University College of Business Administration, Jamaica, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Trinkhaus
authors.forename: J
authors.initials: J
authors.lastname: Nathan
authors.forename: L
authors.initials: L
authors.lastname: Beane
authors.forename: B
authors.initials: B
authors.lastname: Meltzer
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects*; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D035082:Federal Government; D033161:Government Regulation; D006801:Humans; D033181:Information Dissemination; D007676:Kidney Failure, Chronic / Q000139:chemically induced*; D016365:Liability, Legal; D018570:Risk Assessment; D014481:United States
chemical_list: D018712:Analgesics, Non-Narcotic; D000082:Acetaminophen